Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletinHumansMeningococcal VaccinesChildPreschoolNeisseria meningitidis
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023.
Kirsty Foster, Emma J Heymer, Helen Campbell, Emma Wilson, Jess Baldasera, Jay Lucidarme, Stephen A Clark, Xilian Bai, Shazaad Ahmad, Ray Borrow, Shamez N Ladhani
Published: 202610.2807/1560-7917.ES.2026.31.3.2500431
Abstract
In November 2023, the UK Health Security Agency was notified of PCR-confirmed group B (MenB) invasive meningococcal disease (IMD) in a 3-year-old child (Case A), followed by probable IMD in a 2-year-old (Case B, culture and PCR tests negative) attend…
Preview only. Read the full abstract at the source